Abstract
I agree with Dr. Milmore that our statement that "in the type A individual a second cancer is more likely to develop" does require "knowledge of the blood group distribution of patients with only one cancer as well as of patients with two or more cancers." Our original manuscript submitted toThe Journalstated that as blood group controls we could use (1) the white population of the United States or (2) 478 singlecancer white patients taken at random from our survey. The following Table was submitted as Table 5. The manuscript was returned for possible revision. (From the letter of the Staff Editor, I copy the following sentence: "The major criticism raised by our reviewers is that the control data are not ideal...." The statement to which Dr. Milmore refers, and which I copied above, was referred to by the Editor as a statement which does "not necessarily follow
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
